@article{oai:soar-ir.repo.nii.ac.jp:00021350,
 author = {Yazaki, Masahide and Yoshinaga, Tsuneaki and Sekijima, Yoshiki and Kametani, Fuyuki and Okumura, Nobuo},
 issue = {1},
 journal = {INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES},
 month = {Jan},
 note = {Hereditary fibrinogen Aα-chain amyloidosis (Aα-chain amyloidosis) is a type of autosomal dominant systemic amyloidosis caused by mutations in fibrinogen Aα-chain gene (FGA). Patients with Aα-chain amyloidosis have been mainly reported in Western countries but have been rarely reported in Asia, with only five patients with Aα-chain amyloidosis being reported in Korea, China, and Japan. Clinically, the most prominent manifestation in Asian patients with Aα-chain amyloidosis is progressive nephropathy caused by excessive amyloid deposition in the glomeruli, which is similar to that observed in patients with Aα-chain amyloidosis in Western countries. In molecular features in Asian Aα-chain amyloidosis, the most common variant, E526V, was found in only one Chinese kindred, and other four kindred each had a different variant, which have not been identified in other countries. These variants are located in the C-terminal region (amino acid residues 517?555) of mature Aα-chain, which was similar to that observed in patients with Aα-chain amyloidosis in other countries. The precise number of Asian patients with Aα-chain amyloidosis is unclear. However, patients with Aα-chain amyloidosis do exist in Asian countries, and the majority of these patients may be diagnosed with other types of systemic amyloidosis., Article, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.19:320(2018)},
 title = {Hereditary Fibrinogen Aα-Chain Amyloidosis in Asia: Clinical and Molecular Characteristics},
 volume = {19},
 year = {2018}
}